Your browser doesn't support javascript.
loading
Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity.
Graham, Charlotte E; Lee, Won-Ho; Wiggin, Hadley R; Supper, Valentina M; Leick, Mark B; Birocchi, Filippo; Yee, Andrew J; Petrichenko, Angelina; Everett, John; Bushman, Frederic D; Sadrzadeh, Hossein; Rapalino, Otto; Chiu, Daniel; Arrillaga-Romany, Isabel; Maus, Marcela V; Frigault, Matthew J; Gallagher, Kathleen M E.
Afiliación
  • Graham CE; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Lee WH; Department of Medicine, Harvard Medical School, Boston, MA.
  • Wiggin HR; Department of Pathology, Harvard Medical School, Boston, MA.
  • Supper VM; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Birocchi F; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Yee AJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Petrichenko A; Department of Medicine, Harvard Medical School, Boston, MA.
  • Everett J; Department of Pathology, Harvard Medical School, Boston, MA.
  • Bushman FD; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Sadrzadeh H; Department of Medicine, Harvard Medical School, Boston, MA.
  • Rapalino O; Department of Pathology, Harvard Medical School, Boston, MA.
  • Chiu D; Department of Medicine, Harvard Medical School, Boston, MA.
  • Arrillaga-Romany I; Department of Pathology, Harvard Medical School, Boston, MA.
  • Maus MV; Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA.
  • Frigault MJ; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Gallagher KME; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Blood ; 142(14): 1248-1252, 2023 10 05.
Article en En | MEDLINE | ID: mdl-37467494
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Marruecos